ArticleAmerican journal of physiology. Heart and circulatory physiology2025
Cardiac myosin-binding protein-C acts as a tunable load sensor to regulate afterload dependence of ventricular function.
Article in American journal of physiology. Heart and circulatory physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Myosin motor dynamics and cardiac function: Insights from in vivo small-angle X-ray scattering and pressure-volume analysis.The Journal of physiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The sarcomeric protein cardiac myosin-binding protein-C (cMyBP-C) binds myosin on thick filaments and regulates cardiac myocyte contraction. Our lab has reported that permeabilized cardiac myocytes lacking cMyBP-C generate greater power and show disproportionately fast sarcomere shortening velocities at high loads. Also, high-resolution X-ray diffraction of cardiac trabeculae found that myosin cross bridges in the cMyBP-C zone are the most active during loaded contractions. Together, these results implicate cMyBP-C as a potential molecular load sensor. We tested the hypothesis that cMyBP-C is a tunable load sensor that matches afterload and left ventricular (LV) performance. We compared the afterload dependence of LV power between isolated hearts from mice lacking cMyBP-C knockout (KO) or transgenic mice expressing either wild-type (cMyBP-C WT), cMyBP-C carrying pseudo-phosphorylated cMyBP-C (cMyBP-C t3SD), or nonphosphorylatable cMyBP-C (cMyBP-C t3SA). cMyBP-C KO hearts exhibited minimal differences in LV power as a function of afterload from 40 to 60 mmHg. In contrast, cMyBP-C WT hearts exhibited relatively steep afterload dependence of LV power. We also tested whether load sensing is tunable by cMyBP-C phosphorylation. We observed steep afterload dependence of LV power in hearts carrying pseudo-phosphorylated cMyBP-C (cMyBP-C t3SD). Alternatively, hearts with nonphosphorylatable cMyBP-C (cMyBP-C t3SA) exhibited less afterload dependence of LV power. Thus, it appears cMyBP-C acts as a tunable load sensor that matches myofilament power with hemodynamics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.